Genexine
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
About
Genexine is a biopharmaceutical company dedicated to developing innovative biologics to address serious health issues and improve patient lives. They focus on creating novel immunotherapies for cancer and antibody therapies for rare diseases, utilizing proprietary platforms like the long-acting hyFc® Fusion Platform and DNA Vaccine Platform. Their pipeline includes treatments for anemia, growth hormone deficiency, and cervical cancer, aiming to save lives through scientific innovation.
Show 6 more similar companies
Similar companies
A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Shares Biotechnology, Rare Diseases
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Shares Biotechnology, Drug Discovery
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Shares Biotechnology, Immunotherapy
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Shares Biotechnology, Oncology
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Shares Biotechnology, Drug Discovery
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Genexine?
People comparing tools land here. Get listed beside these.
Copy Genexine's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- genexine.com
- Headquarters
- Seoul, South Korea
- Founded
- 1999
- Founder
- Young-Chul Sung
- Total funding
- $296.5M (Funding)
- Business model
- B2B
Funding rounds
- $63.5M21 Dec 2020
- $233M21 Mar 2018Post IPOLargest round
Tech stack
Detected on genexine.com, last scanned 21 Nov 2026. Run your own scan
- Email provider
- Self-hosted
Benchmarking
See how your site ranks against 16,849 startups
Genexine sits in the 43rd percentile for Domain Rating. Check where yours lands, free.
Genexine has a Domain Rating of 35, the 43rd percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursAgent Readiness
Bottom 25%
Scan yoursSecurity
Click to scan
Agent Readiness
Can AI agents use your site?
Genexine scores 28. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Genexine changes
Used Genexine? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Included in market maps
Make a market mapFrequently asked
Who owns Genexine?
Genexine is privately held, owned by its founders and investors. Investors on record include IMM Investment and Mirae Asset. Exact stakes are not public.
Are there companies like Genexine?
Yes. We list 6 companies like Genexine, including Travere Therapeutics, BioNTech and Enterome. Genexine has raised more than 3 of the 5 with funding on record.
How much funding has Genexine raised?
Genexine has raised a total of $296.5M in funding. The most recent round on record is Funding.
SEC filings, insider activity, nonprofit links and pay benchmarks for Genexine:
Company details: from public sources. Funding: 2 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Genexine and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

